文献速递前列腺增生与排尿功能障碍

压力性尿失禁手术不增加盆腔恶性肿瘤风险:基于人群的队列研究

Stress Incontinence Surgery Does Not Cause Pelvic Malignancy: A Population-Based Cohort Study.
PubMed 文献 · J Urol · 2021-04-08

该回顾性队列研究纳入加拿大安大略省2002至2015年间接受压力性尿失禁手术(吊带或非吊带)且无盆腔恶性肿瘤史的女性,对照组为同期无手术女性。中位随访8.5年,手术组盆腔恶性肿瘤风险低于对照组(吊带HR 0.68,非吊带HR 0.37),各盆腔癌种风险均降低。结论认为压力性尿失禁手术未增加盆腔恶性肿瘤风险。

要点

  • 吊带与非吊带压力性尿失禁手术均与盆腔恶性肿瘤风险降低相关。
  • 中位随访8.5年,手术组盆腔恶性肿瘤发生587例。
  • 各盆腔癌种单独分析同样显示风险降低。

核心结论

  • 中位随访8.5年,吊带或非吊带压力性尿失禁手术均未增加盆腔恶性肿瘤风险,且风险低于对照组。

主要发现

  • 中位随访8.5年(IQR 5.5-11.9),手术组发生587例盆腔恶性肿瘤。
  • 与对照组相比,吊带手术组盆腔恶性肿瘤风险降低(HR 0.68,95%CI 0.62-0.76,P<0.0001),非吊带手术组风险亦降低(HR 0.37,95%CI 0.29-0.46,P<0.0001),总体Wald检验P<0.001。
  • 各盆腔癌种单独分析均显示压力性尿失禁手术后恶性肿瘤风险降低。

临床怎么用

  • 对于接受吊带或非吊带压力性尿失禁手术的女性,无需因担心盆腔恶性肿瘤风险而改变手术决策。
  • 术后随访中盆腔恶性肿瘤风险未增加,可据此进行患者咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to determine if stress urinary incontinence surgery (mesh or nonmesh) is associated with the development of pelvic malignancies later in life. MATERIALS AND METHODS: We performed a retrospective cohort study between January 1, 2002 and October 31, 2015 of all women in Ontario, Canada without a history of pelvic malignancy who underwent an index stress incontinence surgery. The primary outcome was a composite of any pelvic malignancy (including urological and gynecological cancers) following stress incontinence surgery. Secondarily, we considered each cancer individually. A survival analysis using a Cox proportional-hazards model with a 3-level categorical exposure (mesh surgery, nonmesh surgery, and control) was performed. Patients were followed until death, emigration or the study end (October 31, 2017). RESULTS: Of the women 74,968 underwent stress urinary incontinence surgery during the study period. There were 5,505,576 women in the control group. Over a median followup of 8.5 years (IQR, 5.5-11.9), 587 pelvic malignancies occurred in the surgery group. Women who underwent stress incontinence surgery had a reduced risk of pelvic malignancy independent of surgery type, compared to controls (Wald type 3 p <0.001; mesh HR, 0.68 [95% CI, 0.62-0.76]; p <0.0001; nonmesh HR, 0.37 [95% CI, 0.29-0.46]; p <0.0001). The individual pelvic cancers similarly demonstrated a reduced risk of malignancy following stress incontinence surgery. CONCLUSIONS: At a median followup of 8.5 years, women had no increased risk of pelvic malignancy following either mesh or nonmesh stress urinary incontinence surgery in a large population-based cohort.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Vigil HR, Wallis CJD, Zhang B, et al. Stress Incontinence Surgery Does Not Cause Pelvic Malignancy: A Population-Based Cohort Study. J Urol. 2021. PMID: 33829862. doi:10.1097/JU.0000000000001631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。